Bruce Taylor

Active 1983–2025

186
Papers
19,345
Citations
77
h-index
164
i10-index

Citations

Citations per year for Bruce Taylor1989: 1 citations1990: 1 citations1991: 2 citations1993: 1 citations1994: 1 citations1995: 3 citations1996: 6 citations1997: 5 citations1998: 2 citations1999: 7 citations2000: 15 citations2001: 19 citations2002: 29 citations2003: 48 citations2004: 56 citations2005: 67 citations2006: 80 citations2007: 58 citations2008: 87 citations2009: 71 citations2010: 157 citations2011: 158 citations2012: 141 citations2013: 139 citations2014: 125 citations2015: 145 citations2016: 102 citations2017: 154 citations2018: 147 citations2019: 541 citations2020: 646 citations2021: 605 citations2022: 468 citations2023: 329 citations2024: 558 citations2025: 295 citations2026: 11 citations1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,490 citing papers, 19.3% of this breakdownUnited Kingdom: 731 citing papers, 9.5% of this breakdownAustralia: 558 citing papers, 7.2% of this breakdownItaly: 427 citing papers, 5.5% of this breakdownCanada: 382 citing papers, 5% of this breakdownGermany: 380 citing papers, 4.9% of this breakdownChina: 356 citing papers, 4.6% of this breakdownNetherlands: 281 citing papers, 3.6% of this breakdownSpain: 249 citing papers, 3.2% of this breakdownFrance: 213 citing papers, 2.8% of this breakdownSweden: 191 citing papers, 2.5% of this breakdownSwitzerland: 165 citing papers, 2.1% of this breakdown
0%19.3%Other 29.8%

Fields

  • Medicine64.6%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Neuroscience6.6%
  • Health Professions3.3%
  • Immunology and Microbiology3.1%
  • Social Sciences2.5%
  • Other9%

Topics

  • Multiple Sclerosis Research Studies11.3%
  • Peripheral Neuropathies and Disorders3.4%
  • Vitamin D Research Studies2.6%
  • Systemic Lupus Erythematosus Research1.5%
  • Neuroinflammation and Neurodegeneration Mechanisms1.5%
  • Tryptophan and brain disorders1.5%
  • Other78.2%

Coauthors

All papers

Open in search
  1. Locus for severity implicates CNS resilience in progression of multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gıancarlo Comı, Chris Cotsapas, Bruce Cree, Sandra D’Alfonso, Efthimios Dardiotis, Philip L. De Jager, Silvia Delgado, Bénédicte Dubois, Sinah Engel, Federica Esposito, Marzena J. Fabis‐Pedrini, Massimo Filippi, Kathryn C. Fitzgerald, Christiane Gasperi, Lissette Gomez, Refujia Gomez, Georgios M. Hadjigeorgiou, Jörg Hamann, Friederike Held, Roland G. Henry, Jan Hillert, Jesse Huang, Inge Huitinga, Talat Islam, Noriko Isobe, Maja Jagodic, Allan G. Kermode, Michael Khalil, Trevor J. Kilpatrick, Ioanna Konidari, Karim L. Kreft, Jeannette Lechner‐Scott, Maurizio Leone, Felix Luessi, Sunny Malhotra, Ali Manouchehrinia, Clara P. Manrique, Filippo Martinelli Boneschi, Andrea C. Martinez, Viviana Martínez-Maldonado, Elisabetta Mascia, Luanne M. Metz, Luciana Midaglia, Xavier Montalbán, Jorge R. Oksenberg, Tomas Olsson, Annette Oturai, Kimmo Pääkkönen, Grant P. Parnell, Nikolaos A. Patsopoulos, Margaret A. Pericak‐Vance, Fredrik Piehl, Justin P. Rubio, Adam Santaniello, Silvia Santoro, Catherine Schaefer, Finn Sellebjerg, Hengameh Shams, Klementy Shchetynsky, Cláudia Silva, Vasileios Siokas, Helle Bach Søndergaard, Melissa Sorosina, Bruce Taylor, Marijne Vandebergh, Elena S. Vasileiou, Domizia Vecchio, Margarete M. Voortman, Howard L. Weiner, Dennis Wever and 21 more - Nature 2023 cited by 227

  2. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

    Authors: , , , , , , - Neurology 2014 cited by 1,249

  3. Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan I. Epstein, Daniel D. Evans, Paul Fulford, Wolfgang B. Gaertner, Jean‐Pierre Gérard, Simon Gollins, Ryan A. Harris, Ewen M. Harrison, J. Heat, Jordan Hill, J Hobbiss, Eduardo Huertas, Zahirul Huq, Soledad Iseas, Anders Jakobsen, Derek A. Jones, Leslie S. Jones, Uzair Ali Khan, RS Kushwaha, Nicholas P. Lees, TY Linn, S Loganathan, Fernando López‐Campos, Robert D. Madoff, З. З. Мамедли, Anna Martling, Klaus E. Matzel, Jarno Melenhorst, Philip B. Mitchell, Sthela M. Murad‐Regadas, Sarah O’Dwyer, Alejandro Pairola, Marius Paraoan, Oriol Parés, Koen Peeters, S H Pettit, N Pranesh, R Rajaganeshan, Srinivasan Ravi, Shyamji Rawat, David M. Richards, K Riyad, Gustavo Rossi, H.J.T. Rutten, M. Saeed, J.R. Salaman, Fernando Sánchez Loria, Marit E. van der Sande, Inês Santiago, Chelliah Selvasekar, K.H. Siddiqui, Christopher J. Smart, Mamoon Solkar, Arthur Sun Myint, Bruce Taylor, Karen Telford, Nigel Scott, Carlos Vaccaro, Bruna Borba Vailati, C Verberne, Pedro Vieira, Dale Vimalchandran, Sarah V. Ward, Malcolm Wilson, D. C. Winter, Carlijn Witjes, Albert Wolthuis, Jing Zhang, Zhen Zhang - The Lancet Oncology 2020 cited by 210

  4. The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice

    Authors: , , , , , , , , , , , , , , , - Cancers 2021 cited by 104

  5. Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases

    Authors: , , , , , , , , , - Nature Communications 2021 cited by 113

  6. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression

    Authors: , , , , , , , , - Scientific Reports 2017 cited by 261

  7. Consumer Reports of “Keto Flu” Associated With the Ketogenic Diet

    Authors: , , , - Frontiers in Nutrition 2020 cited by 102

  8. Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marcos Burgos, Juan Carlos Giugni, Juan Jose Martin Artesi, Juan Ignacio Rojas, Daniel Raul Zuin, Hugo Osvaldo Videla, Jorge Daniel Correale, Geraldine G. Luetic, Suzanne Hodgkinson, Jeannette Lechner-Scott, John Parratt, Noel Saines, Stephen Reddel, Tissa Wijeratne, Bruce Taylor, Florian Deisenhammer, Gerhard Traxler, Fritz Leutmezer, Peter Wipfler, Joerg R. Weber, Christian Lampl, Emmanuel Bartholome, Dominique Dive, Nele Glibert, Gaetano Perrotta, Vincent Pesch, Maarten Buyle, Bart Wijmeersch, Barbara Willekens, Edin Basagic, Enra Mehmedika Suljic, Inge Klupka-Sarić, Maya Danovska, Maria Dimitrova, Krasimir Genov, Alim Izmaylov, Radoslav Mavrov, Ivan Milanov, Valcho Naydenov, Penko Shotekov, Ivaylo Tarnev, Latchezar Traykov, Francois Emond, Daniel Selchen, Donald Rivest, Lisa Sabella, Ludivine Witkowski, Alexander Saveriano, Addinson Rene Bolano Solano, Cesar Augusto Franco Ruiz, Andrea Catalina Nassar Tobon, Carlos Alberto Navas Cardozo, Antonio Schlesenger, Javier Dario Triana, Osvaldo Elias Lara Sarabia, Luis Alfonso Zarco Montero, Jorge Andres Jimenez Arango, Silvio Basic, Marija Bosnjak Pasic, Silva Butkovic Soldo, Mario Habek, Spomenka Kidjemet-Piskac, Meri Matijaca, Vladimira Vuletic, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Jan Mares, Alena Martinkova, Marek Peterka and 607 more - The Lancet Neurology 2024 cited by 72

  9. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

    Authors: , , , , - Journal of Neurology Neurosurgery & Psychiatry 2011 cited by 711

  10. “If they don’t tell us what they do with it, why would we trust them?” Trust, transparency and benefit-sharing in Smart Farming

    Authors: , , , , , , - NJAS - Wageningen Journal of Life Sciences 2018 cited by 288

  11. The Current Status of the Ketogenic Diet in Psychiatry

    Authors: , , - Frontiers in Psychiatry 2017 cited by 130

  12. Digitalisation of agricultural knowledge and advice networks: A state-of-the-art review

    Authors: , , - Agricultural Systems 2020 cited by 295

  13. Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandra Lugaresi, Samia J. Khoury, Mark Slee, Recai Türkoğlu, Suzanne Hodgkinson, Nevin John, Davide Maimone, María José Sá, Vincent Van Pesch, Oliver Gerlach, Guy Laureys, Liesbeth Van Hijfte, Rana Karabudak, Daniele Spitaleri, Tünde Csépány, Riadh Gouider, Tamara Castillo‐Triviño, Bruce Taylor, Basil Sharrack, John A. Snowden, MSBase Study Group Collaborators, MSBase Study Group Authors, Dana Horáková, Katherine Buzzard, Murat Terzi, Alexandre Prat, Marc Girard, Pierre Grammond, Michael Barnett, Grace Stewart, Marco Onofrj, Guillermo Izquierdo, Sara Eichau, François Grand’Maison, Julie Prévost, Bart Van Wijmeersch, Maria Pia Amato, Vahid Shaygannejad, Cavit Boz, R. Fernandez Bolanos, Aysun Soysal, Cristina Ramo‐Tello, Claudio Solaro, Claudio Gobbi, José Antonio Cabrera-Gómez, E Roullet, Cees Zwanikken, Leontien Den Braber‐Moerland, Norma Deri, Maria Luisa Saladino, Edgardo Cristiano, Juan Ignacio Rojas, Cárlos Vrech, Cameron Shaw, Neil Shuey, Mike Boggild, Ik Lin Tan, Todd A. Hardy, D. Decoo, Fraser Moore, Jiwon Oh, Patrice H. Lalive, Radek Ampapa, Thor Petersen, Celia Oreja‐Guevara, Ángel Pérez Sempere, José Andrés Domínguez, Sarah Besora, Stella Hughes, Orla Gray and 55 more - JAMA Neurology 2023 cited by 52

  14. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype

    Authors: , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2015 cited by 426

  15. Latitude continues to be significantly associated with the prevalence of multiple sclerosis: an updated meta-analysis

    Authors: , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 145

  16. Vitamin D for the treatment of multiple sclerosis: a meta-analysis

    Authors: , , , , , - Journal of Neurology 2018 cited by 115

  17. Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Slee, Steve Vucic, Radek Ampapa, Pamela McCombe, Cristina Ramo‐Tello, Julie Prévost, Javier Olascoaga, Edgardo Cristiano, Michael Barnett, María Laura Saladino, José Luis Sánchez-Menoyo, Suzanne Hodgkinson, Csilla Rózsa, Stella Hughes, Fraser Moore, Cameron Shaw, Ernest Butler, Olga Skibina, Orla Gray, Allan G. Kermode, Tünde Csépány, Bhim Singhal, Neil Shuey, Piroska Imre, Bruce Taylor, Magdolna Simó, Carmen Adella Sîrbu, Attila Sas, Helmut Butzkueven - Neurology 2020 cited by 98

  18. Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nadia Mubder Issa, Matthias Kant, Finn Sellebjerg, Orla Gray, Melinda Magyari, Tomáš Kalinčík, MSBase Study GroupDanish MS Registry Study Group, José Antonio Cabrera-Gómez, E Roullet, Cees Zwanikken, Leontien Den Braber‐Moerland, Michael Barnett, Suzanne Hodgkinson, Justin Garber, Mark Slee, Pamela McCombe, Bruce Taylor, Richard Macdonell, Jennifer Massey, Vincent Van Pesch, D. Decoo, Barbara Willekens, Yára Dadalti Fragoso, Julie Prévost, Alexandre Prat, Marc Girard, Pierre Grammond, Catherine Larochelle, Jiwon Oh, Patrice H. Lalive, Claudio Gobbi, Dana Horáková, Eva Havrdová, Radek Ampapa, Guillermo Izquierdo, Sara Eichau, José Luis Sánchez-Menoyo, Cristina Ramo‐Tello, Yolanda Blanco, Albert Saiz, Sarah Besora, Vahid Shaygannejad, Elisabetta Cartechini, Matteo Diamanti, Maria Pia Amato, Daniele Spitaleri, Francesco Patti, Clara Grazia Chisari, Emanuele D’Amico, L Salvatore, Bassem Yamout, Samia J. Khoury, Abdullah Al‐Asmi, María José Sá, Talal Al‐Harbi, Rana Karabudak, Recai Türkoğlu, Trevor J. Kilpatrick, John King, Ai‐Lan Nguyen, Chris Dwyer, Mastura Monif, Lisa Taylor, Josephine Baker - JAMA Neurology 2023 cited by 60

  19. The latitude gradient for multiple sclerosis prevalence is established in the early life course

    Authors: , , , , , - Brain 2021 cited by 59

  20. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects

    Authors: , , , , , , , , , , , , , , , , , , - PLoS Genetics 2013 cited by 311

  21. Risk of secondary progressive multiple sclerosis: A longitudinal study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Radek Ampapa, Aysun Soysal, Thor Petersen, José Luis Sánchez-Menoyo, Freek Verheul, Julie Prévost, Youssef Sidhom, Bart Van Wijmeersch, Steve Vucic, Edgardo Cristiano, Maria Luisa Saladino, Norma Deri, Michael Barnett, Javier Olascoaga, Fraser Moore, Olga Skibina, Orla Gray, Yára Dadalti Fragoso, Bassem Yamout, Cameron Shaw, Bhim Singhal, Neil Shuey, Suzanne Hodgkinson, Ayşe Altıntaş, Talal Al‐Harbi, Tünde Csépány, Bruce Taylor, Jordana Hughes, Jae-Kwan Jun, Anneke van der Walt, Tim Spelman, Helmut Butzkueven, Tomáš Kalinčík - Multiple Sclerosis Journal 2019 cited by 83

  22. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Brain 2022 cited by 50

  23. Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis

    Authors: , , , , , , , , - Annals of Neurology 2010 cited by 452

  24. Multifocal motor neuropathy: controversies and priorities

    Authors: , , , , - Journal of Neurology Neurosurgery & Psychiatry 2019 cited by 107